Stay updated on Selinexor Maintenance in p53 Wild-Type Endometrial Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Selinexor Maintenance in p53 Wild-Type Endometrial Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Selinexor Maintenance in p53 Wild-Type Endometrial Carcinoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    No additions or deletions detected; the Study Details page content remains unchanged.
    Difference
    0.1%
    Check dated 2025-10-31T12:08:13.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Publications section updated: added Secord et al., Molecular Characterization and Clinical Implications of Endometrial Cancer (Obstet Gynecol, 2025; 146(5):660-671; Epub 2025 Sep 18), and removed the previous 'Online ahead of print' listing for the same article. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-10-24T08:11:23.000Z thumbnail image
  3. Check
    25 days ago
    Change Detected
    Summary
    Expanded and detailed trial protocol and site information for selinexor maintenance in endometrial cancer, with updated eligibility, endpoints, and locations; replaces a shorter prior description.
    Difference
    31%
    Check dated 2025-10-10T00:25:13.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    Page updated to version v3.2.0 with extensive new contact details added; older v3.0.2 deletion indicates a release upgrade. The main change is a content and contact-data refresh.
    Difference
    0.0%
    Check dated 2025-10-01T03:59:52.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Updated contact details and added a new revision tag (v3.1.0); removed the old revision tag (v3.0.2).
    Difference
    0.0%
    Check dated 2025-09-30T02:55:50.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Added a new scholarly citation: Secord et al. on molecular characterization of endometrial cancer (Obstet Gynecol, 2025). No deletions present.
    Difference
    0.3%
    Check dated 2025-09-22T23:40:15.000Z thumbnail image

Stay in the know with updates to Selinexor Maintenance in p53 Wild-Type Endometrial Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Selinexor Maintenance in p53 Wild-Type Endometrial Carcinoma Clinical Trial page.